Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2024 09:26 ET | Source: Research and Markets

Angina Global Market Report 2024: A $13.61 Billion Market in 2028, Registering a Compound Annual Growth Rate (CAGR) of 6.2%

Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "Angina Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The angina market size has grown strongly in recent years, from...
August 30, 2024 08:00 ET | Source: Imbria Pharmaceuticals Inc.

Imbria to Present Results from Phase 2 IMPROVE-ISCHEMIA Trial of Ninerafaxstat in Patients with Angina and Chronic Coronary Syndrome at the European Society of Cardiology Congress 2024

– Ninerafaxstat was well tolerated and showed no impact on systemic hemodynamics in patients with stable angina and chronic coronary syndrome – – These findings support a direct,...
August 22, 2023 07:56 ET | Source: Research Nester

Atenolol Market revenue to cross USD 28 Billion by 2035, says Research Nester

New York, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The global Atenolol Market size is expected to expand at ~ 5% CAGR from 2023 to 2035. The market is anticipated to garner a revenue of USD 28 billion by...
March 07, 2023 14:30 ET | Source: Transparency Market Research

Inotropic Agents Market Value to Surpass US$ 5.1 Bn by 2031: TMR Study

Wilmington, Delaware, United States, March 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – As per a TMR study, the Inotropic Agents Market was valued at US$ 1.9 Bn in 2022 and is...
October 21, 2021 06:58 ET | Source: Research and Markets

Worldwide Diltiazem Industry to 2028 - Increase in Cardiovascular Disease Incidence is Driving Growth

Dublin, Oct. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Diltiazem Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Capsules, Injection, and Tablets); Application (Angina,...
September 09, 2020 06:53 ET | Source: Research and Markets

Outlook on the Global Refractory Angina Industry to 2030 - 11-Year Forecast of Refractory Angina Epidemiology

Dublin, Sept. 09, 2020 (GLOBE NEWSWIRE) -- The "Refractory Angina (RA) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth...
January 31, 2020 09:00 ET | Source: Neovasc, Inc.

Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina

Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure VANCOUVER, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or...
February 13, 2013 13:26 ET | Source: PlatformQ, the Leader in Live Online Events

Cardiology Care Leaders Unite to Educate Over 1,000 Physicians on Diagnostic Protocols and Treatment Strategies At CardioCareLive

NEEDHAM, Mass., Feb. 13, 2013 (GLOBE NEWSWIRE) -- CardioCareLive, the website for live interactive video cardiology conferences, today announced that more than 1,000 clinicians attended the Johns...